Revising the guideline on first-in-human clinical trials


The EMA yesterday published a guideline:

Draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products

The document can be found here.

The consultation period ends 28-Feb-2017.

This entry was posted in Other News and tagged . Bookmark the permalink.

Comments are closed.